Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
36 rows where has_known_aptamer = 1, in_cev_map = 0 and surface_class = "A2_pm_peripheral" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: evidence_priority, pdb_count_total, aptamer_count_pubmed, opentargets_top_disease_name
surface_class 1
- A2_pm_peripheral · 36 ✖
in_cev_map 1
- - · 36 ✖
has_known_aptamer 1
- 1 · 36 ✖
has_activation_state_pdb_pair 1
- 0 36
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P25054 | APC | Adenomatous polyposis coli protein | Tier 1 | 0.644 | 1 | A2_pm_peripheral | 31 | 0 | 0 | 1 | 39 | 41471356, 40788329, 40207978, 39796151, 39335496, 39189513, 38710049, 38509823, 37199793, 37185533, 36894782, 36882463, 36827736, 36252203, 35544380, 35490167, 34837173, 34708097, 34240523, 34008621, 32486960, 32429721, 32386347, 31937772, 31295701, 31249960, 30609568, 29886066, 29666278, 27736370, 27427891, 26552824, 26552816, 25059182, 24681393, 22236082, 19389630, 19029139, 9546673 | 0 | familial adenomatous polyposis 1 | 0.8462165290909345 | |||
| P15104 | GLUL | Glutamine synthetase | Tier 1.5 | 0.622 | 1 | A2_pm_peripheral | 12 | 97.5 | 1 | 0 | 1 | 4 | 39533430, 30085248, 21282981 | 0 | congenital brain dysgenesis due to glutamine synthetase deficiency | 0.7733687702812198 | ||
| P10636 | MAPT | Microtubule-associated protein tau | Tier 1 | 0.618 | 1 | A2_pm_peripheral | 100 | 49.22 | 1 | 0 | 1 | 9 | 40380000, 39241336, 38585969, 38397086, 37003060, 31900535, 30004544, 29268187 | 0 | Pick disease | 0.7600399335134378 | ||
| P12643 | BMP2 | Bone morphogenetic protein 2 | Tier 1 | 0.611 | 1 | A2_pm_peripheral | 21 | 79.56 | 0 | 0 | 1 | 10 | 41144653, 38542880, 37231465, 35591468, 35195734, 34067593, 33997500 | 0 | short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1 | 0.7361833785834584 | ||
| O14640 | DVL1 | Segment polarity protein dishevelled homolog DVL-1 | Tier 1.5 | 0.611 | 1 | A2_pm_peripheral | 3 | 59.84 | 0 | 0 | 1 | 1 | 37231925 | 0 | autosomal dominant Robinow syndrome | 0.7359277384599506 | ||
| P41159 | LEP | Leptin | Tier 1 | 0.606 | 1 | A2_pm_peripheral | 10 | 81.12 | 1 | 0 | 1 | 14 | 40330320, 40008515, 39263947, 37331044, 36508319, 36173490, 35884340, 34016094, 33650854, 32527800, 27530235, 26529285, 23232067, 20594164 | 0 | obesity due to congenital leptin deficiency | 0.7197450249224271 | ||
| Q2Q1W2 | TRIM71 | E3 ubiquitin-protein ligase TRIM71 | Tier 1.5 | 0.578 | 1 | A2_pm_peripheral | 2 | 79.12 | 0 | 0 | 1 | 2 | 31732746 | 0 | hydrocephalus, congenital communicating, 1 | 0.6276048232841862 | ||
| P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Tier 1 | 0.555 | 1 | A2_pm_peripheral | 6 | 75.75 | 0 | 0 | 1 | 1 | 34962102 | 0 | alopecia areata | 0.5491699656070116 | ||
| Q96RU8 | TRIB1 | Tribbles homolog 1 | Tier 1 | 0.552 | 1 | A2_pm_peripheral | 5 | 76.56 | 0 | 0 | 1 | 1 | 36579647 | 0 | neurodegenerative disease | 0.5397808385585621 | ||
| Q5TC82 | RC3H1 | Roquin-1 | Tier 1 | 0.545 | 1 | A2_pm_peripheral | 6 | 61.12 | 0 | 0 | 1 | 2 | 27010430 | 0 | hemophagocytic lymphohistiocytosis, familial, 6 | 0.5161798637096334 | ||
| Q96AT9 | RPE | Ribulose-phosphate 3-epimerase | Tier 1 | 0.54 | 1 | A2_pm_peripheral | 4 | 96.56 | 0 | 0 | 1 | 19 | 37958909, 31080896, 26923800, 25270019, 23539459, 22913867, 22710369, 22281826, 21701525, 21546514, 21448811, 21137477, 20623466, 19197318, 18628724, 18441313, 17891009, 17369776, 16815269 | 0 | neurodegenerative disease | 0.4992627094132485 | ||
| Q96MU7 | YTHDC1 | YTH domain-containing protein 1 | Tier 1 | 0.533 | 1 | A2_pm_peripheral | 100 | 60.34 | 0 | 0 | 1 | 1 | 41430607 | 0 | neurodegenerative disease | 0.47698771849556626 | ||
| P43351 | RAD52 | DNA repair protein RAD52 homolog | Tier 1 | 0.528 | 1 | A2_pm_peripheral | 11 | 69.62 | 1 | 0 | 1 | 6 | 37288783, 32945515, 31495919, 26784987, 24500205, 23836560 | 0 | Abnormality of the skeletal system | 0.45994164258033876 | ||
| Q9Y2K6 | USP20 | Ubiquitin carboxyl-terminal hydrolase 20 | Tier 1.5 | 0.509 | 1 | A2_pm_peripheral | 1 | 72.31 | 0 | 0 | 1 | 1 | 30863411 | 0 | connective tissue neoplasm | 0.3981371748391643 | ||
| O75182 | SIN3B | Paired amphipathic helix protein Sin3b | Tier 1.5 | 0.501 | 1 | A2_pm_peripheral | 4 | 68.0 | 1 | 0 | 1 | 2 | 16914451 | 0 | syndromic intellectual disability | 0.37050380432141355 | ||
| P32298 | GRK4 | G protein-coupled receptor kinase 4 | Tier 1.5 | 0.49 | 1 | A2_pm_peripheral | 1 | 88.69 | 0 | 0 | 1 | 2 | 31555351 | 0 | Nausea and vomiting | 0.33267400228074584 | ||
| Q13569 | TDG | G/T mismatch-specific thymine DNA glycosylase | Tier 1 | 0.472 | 1 | A2_pm_peripheral | 21 | 70.19 | 0 | 0 | 1 | 5 | 34906054, 33568907, 33015024, 32649855, 32280216 | 0 | venous thromboembolism | 0.2744822808753576 | ||
| P55089 | UCN | Urocortin | Tier 1.5 | 0.469 | 1 | A2_pm_peripheral | 6 | 68.25 | 1 | 0 | 1 | 3 | 30221506, 26488412, 23248006 | 0 | neurodegenerative disease | 0.26311734927710556 | ||
| Q9NYZ3 | GTSE1 | G2 and S phase-expressed protein 1 | Tier 1 | 0.462 | 1 | A2_pm_peripheral | 2 | 50.94 | 0 | 0 | 1 | 1 | 41902775 | 0 | Paroxysmal supraventricular tachycardia | 0.240265138515043 | ||
| P19957 | PI3 | Elafin | Tier 1.5 | 0.446 | 1 | A2_pm_peripheral | 3 | 72.25 | 0 | 0 | 1 | 3 | 37351609, 36517803, 30087279 | 0 | Abruptio Placentae | 0.18626794135552627 | ||
| P01887 | B2m | Beta-2-microglobulin | Tier 1 | 0.39 | 1 | A2_pm_peripheral | 100 | 93.81 | 0 | 0 | 1 | 15 | 41850110, 40373155, 38904251, 40658810, 35026285, 32631049, 29281176, 28960840, 25100729, 20616783, 19137104, 17878167 | 0 | ||||
| P16213 | B2M | Beta-2-microglobulin | Tier 1 | 0.39 | 1 | A2_pm_peripheral | 9 | 94.19 | 0 | 0 | 1 | 15 | 41850110, 40373155, 38904251, 40658810, 35026285, 32631049, 29281176, 28960840, 25100729, 20616783, 19137104, 17878167 | 0 | ||||
| K7N5M4 | B2M | Tier 1 | 0.39 | 1 | A2_pm_peripheral | 24 | 90.94 | 0 | 0 | 1 | 3 | 41850110, 40373155, 38904251 | 0 | |||||
| K7N5M3 | B2M | Tier 1 | 0.39 | 1 | A2_pm_peripheral | 22 | 87.81 | 0 | 0 | 1 | 3 | 41850110, 40373155, 38904251 | 0 | |||||
| P16110 | Lgals3 | Galectin-3 | Tier 1 | 0.39 | 1 | A2_pm_peripheral | 5 | 72.44 | 0 | 0 | 1 | 4 | 39681229, 31418072 | 0 | ||||
| A0A2K6KCS5 | YTHDC1 | YTH domain-containing family protein | Tier 1 | 0.39 | 1 | A2_pm_peripheral | 2 | 53.59 | 0 | 0 | 1 | 1 | 41430607 | 0 | ||||
| Q9H4F8 | SMOC1 | SPARC-related modular calcium-binding protein 1 | Tier 1.5 | 0.388 | 0 | A2_pm_peripheral | 0 | 73.31 | 0 | 0 | 1 | 1 | 36333824 | 0 | microphthalmia with limb anomalies | 0.8103774498041117 | ||
| Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | Tier 1.5 | 0.374 | 0 | A2_pm_peripheral | 0 | 95.81 | 0 | 0 | 1 | 10 | 40271962, 35780537, 35539643, 26547498, 24994506 | 0 | Alpha-methylacyl-CoA racemase deficiency | 0.762086344446303 | ||
| O14543 | SOCS3 | Suppressor of cytokine signaling 3 | Tier 1.5 | 0.287 | 0 | A2_pm_peripheral | 0 | 71.88 | 0 | 0 | 1 | 2 | 39571081 | 0 | neurodegenerative disease | 0.47223972419523075 | ||
| Q9P2M7 | CGN | Cingulin | Tier 1.5 | 0.251 | 0 | A2_pm_peripheral | 0 | 69.56 | 0 | 0 | 1 | 3 | 35297595, 33476120, 21342520 | 0 | Abnormality of the skeletal system | 0.3547927821140923 | ||
| Q8WW22 | DNAJA4 | DnaJ homolog subfamily A member 4 | Tier 1.5 | 0.241 | 0 | A2_pm_peripheral | 0 | 84.44 | 0 | 0 | 1 | 2 | 41935727, 33879515 | 0 | coronary atherosclerosis | 0.3210951574534216 | ||
| Q9Y5Z7 | HCFC2 | Host cell factor 2 | Tier 1.5 | 0.235 | 0 | A2_pm_peripheral | 0 | 72.88 | 0 | 0 | 1 | 24 | 41651417, 41187655, 40586934, 40410820, 40371468, 38829419, 38471488, 36836536, 36517803, 36480517, 34132569, 32981365, 32884147, 32157871, 32101978, 31985806, 31077760, 25534780, 23770039, 20967861, 20445260, 19195013, 15629041, 12177446 | 0 | neurodegenerative disease | 0.29928415571034084 | ||
| Q6XZB0 | LIPI | Lipase member I | Tier 1.5 | 0.215 | 0 | A2_pm_peripheral | 0 | 89.44 | 0 | 0 | 1 | 2 | 32981012, 27715478 | 0 | metabolic disease | 0.23399905961107478 | ||
| Q8N143 | BCL6B | B-cell CLL/lymphoma 6 member B protein | Tier 1.5 | 0.199 | 0 | A2_pm_peripheral | 0 | 54.31 | 0 | 0 | 1 | 1 | 41169059 | 0 | tympanic membrane perforation | 0.18130132303178323 | ||
| Q16206 | ENOX2 | Ecto-NOX disulfide-thiol exchanger 2 | Tier 1.5 | 0.167 | 0 | A2_pm_peripheral | 0 | 77.06 | 0 | 0 | 1 | 2 | 37504074 | 0 | chronic myelogenous leukemia | 0.0726224414455439 | ||
| O77932 | DXO | Decapping and exoribonuclease protein | Tier 1.5 | 0.161 | 0 | A2_pm_peripheral | 0 | 92.69 | 0 | 0 | 1 | 2 | 27432610 | 0 | breast cancer | 0.05174117965585824 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;